127
CORDLIFE GROUP LIMITED
| ANNUAL REPORT 2015
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 JUNE 2015
39.
SEGMENT REPORTING
For management reporting purposes, the Group monitors the performance of the business units based on
their products and services and has two reportable segments as follows:
•
The banking segment comprises of cord blood and cord lining services. Cord blood and cord lining is
collected, processed and stored in the various laboratories in the regions that the Group operates in.
•
The diagnostics segment comprises Metascreen, which is a comprehensive metabolic screening test
specially designed for newborn babies.
The following items and associated assets and liabilities are not allocated to operating segments as they are
not considered part of the core operations of any segment:
•
Interest income excluding interest income on long-term trade receivables.
•
Income taxes that are managed on a group basis.
•
Subsidiaries not in the principal activities of the provision of cord blood and cord lining banking services
and metabolic screening.
No operating segments have been aggregated to form the above reportable operating segments.
Segment revenue
Banking Diagnostics
Others*
Total
$’000
$’000
$’000
$’000
Year ended 30 June 2015
Revenue from external customers
57,436
103
44
57,583
Total consolidated revenue
57,583
Year ended 30 June 2014
Revenue from external customers
48,951
7
129
49,087
Total consolidated revenue
49,087
*
Others refer to the revenue of subsidiaries not in the principal activities of the provision of cord blood and cord lining banking
and diagnostics services.
